Abstract
ObjectivesTo investigate the complications and survival of elderly patients with end-stage renal disease (ESRD) who received urgent-start peritoneal dialysis (USPD) or urgent-start haemodialysis (USHD), and to explore the value of peritoneal dialysis (PD) as the emergent dialysis method for elderly patients with ESRD.DesignRetrospective cohort study.SettingTwo tertiary care hospitals in Shanghai, China.ParticipantsChinese patients (n=542) >65 years of age with estimated glomerular filtration rate ≤15 mL/min/m2who received urgent-start dialysis between 1 January 2005 and 31 December 2015, and with at least 3 months of treatment. Patients who converted to other dialysis methods, regardless of the initial dialysis method, were excluded, as well as those with comorbidities that could significantly affect their dialysis outcomes.Primary and secondary outcome measuresDialysis-related complications and survival were compared. Patients were followed until death, stopped PD, transfer to other dialysis centres, loss to follow-up or 31 December 2016.ResultsThere were 309 patients in the USPD group and 233 in the USHD group. The rate of dialysis-related complications within 30 days after catheter implantation was significantly lower in the USPD group compared with the USHD group (4.5% vs 10.7%, p=0.031). The 6-month and 1, 2 and 3-year survival rates were 95.3%, 91.4%, 86.6% and 64.8% in the USPD group, and 92.2%, 85.7%, 70.2% and 57.8% in the USHD group, respectively (p=0.023). The multivariable Cox regression analysis showed that USHD (HR=2.220, 95% CI 1.298 to 3.790; p=0.004), age (HR=1.025, 95% CI 1.013 to 1.043, p<0.001) and hypokalaemia (HR=0.678, 95% CI 0.487 to 0.970; p=0.032) were independently associated with death.ConclusionsUSPD was associated with slightly better survival compared with USHD. USPD was associated with fewer complications and better survival than USHD in elderly patients with ESRD.
Funder
National Key Research and Development Program of China
Shanghai Top Priority Key Clinical Disciplines Construction Project
Shanghai Science and technology commission Foundation
Shanghai Integration of Chinese and Western Medicine Foundation
Reference49 articles.
1. Nephrology update: end-stage renal disease and renal replacement therapy;Desai;FP Essent,2016
2. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease
3. United States Renal Data System . incidence, prevalence, patient characteristics, and treatment modalities. In: USRDS 2014 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. 2. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2014.
4. Worldwide access to treatment for end-stage kidney disease: a systematic review
5. Current burden and probable increasing incidence of ESRD in China;Zuo;Clin Nephrol,2010